Anavex Life Sciences Corp. (AVXL)

NASDAQ: AVXL · Real-Time Price · USD

3.385

+0.045 (1.35%)

Aug 10, 2026, 2:47 PM EDT - Market open

Anavex Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	127.42	102.58	132.19	151.02	149.16	152.11
Cash & Short-Term Investments	127.42	102.58	132.19	151.02	149.16	152.11
Cash Growth	10.06%	-22.40%	-12.47%	1.25%	-1.94%	420.04%
Other Receivables	0.93	0.81	2.45	2.71	3.19	9.14
Total Trade Receivables	0.93	0.81	2.45	2.71	3.19	9.14
Other Current Assets	0.41	0.43	0.93	0.65	0.35	0.37
Total Current Assets	128.77	103.82	135.57	154.39	152.71	161.62
Total Assets	128.77	103.82	135.57	154.39	152.71	161.62

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Accounts Payable	2.52	4.25	9.63	4.32	3.83	4.74
Accrued Expenses	3.73	3.89	4.84	7.3	5.95	5.61
Unearned Revenue	0.81	0.81	0.84	0.92	0.44	0.44
Total Current Liabilities	7.06	8.95	15.3	12.53	10.21	10.8
Total Liabilities	7.06	8.95	15.3	12.53	10.21	10.8

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Common Stock	-	0.09	0.09	0.08	0.08	0.08
Additional Paid-in Capital	515.08	477.23	456.25	434.84	387.98	348.33
Retained Earnings	-393.47	-382.45	-336.07	-293.07	-245.56	-197.59
Shareholders' Equity	121.71	94.87	120.26	141.85	142.49	150.82
Total Liabilities & Equity	128.77	103.82	135.57	154.39	152.71	161.62

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Net Cash (Debt)	127.42	102.58	132.19	151.02	149.16	152.11
Net Cash Growth	10.06%	-22.40%	-12.47%	1.25%	-1.94%	420.04%
Net Cash Per Share	1.44	1.20	1.58	1.89	1.94	2.18
Book Value	121.71	94.87	120.26	141.85	142.49	150.82
Book Value Per Share	1.38	1.11	1.44	1.78	1.85	2.16
Tangible Book Value	121.71	94.87	120.26	141.85	142.49	150.82
Tangible Book Value Per Share	1.38	1.11	1.44	1.78	1.85	2.16

SEC Filings: 10-K · 10-Q